Search

everythinglearnresearchcommunity

for

Search:↓

A gene mutation in mice causes hair loss, weak bones, and protein buildup, showing how protein processing issues can lead to diseases.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.

The G60S Connexin43 mutation causes hair growth issues and poor hair quality in mice, similar to human ODDD patients.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

The Gsdma3 gene is essential for normal hair development in mice.

Dietary L-serine supplementation can reduce symptoms of HSAN1 by lowering harmful 1-deoxySL levels.

Mutations in the SNRPE gene cause hereditary hair loss.

TRPV3 gene mutations cause Olmsted syndrome symptoms, but severity varies.

Certain genetic variants in ERN1, TACR3, and SPPL2C are linked to when Alzheimer's disease starts.

Three new types of a skin blistering disease were found, caused by specific gene mutations.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

A vitamin D receptor mutation causes rickets and affects immune responses.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

A mutation in the KRT86 gene causes hair fragility in a Turkish family.

The polyG fragment in Hoxc13 protein helps evolve mammalian skin and hair by enhancing gene interactions.

Too much keratin 16 in mice skin causes abnormal skin thickening and structure.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Monitor for early signs of azathioprine toxicity and check blood counts regularly.

A chromosomal change may cause ectodermal dysplasia and developmental issues in a child.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Gujian oral liquid reduces osteoarthritis symptoms by targeting inflammation.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

Mutations in the DSG4 gene cause fragile, sparse hair in humans, mice, and rats.

A new genetic mutation in the hairless gene causes a rare hair loss disorder.

Mutations in the SHH pathway in certain skin cells can cause skin tumors and abnormal hair growth.

A variant in the KRT31 gene causes a rare hereditary hair disorder called monilethrix.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.